Industry Voice: China health care innovation

Why are we so excited by drug innovation in China?

clock • 1 min read
Industry Voice: China health care innovation

For Professional Clients only

 

Initiatives to stimulate innovation, especially around drug research and development (R&D), have been the most impactful, in our view.

The result is a booming drug R&D ecosystem including quality biotechs and their R&D outsourcing partner companies.

We expect reforms to provide tremendous industry tailwinds for the next decade and, as long-term investors in this space, we are excited about the new opportunities that are being created.

 

 

 

Investment risks

The value of investments and any income will fluctuate (this may partly be the result of exchange rate fluctuations) and investors may not get back the full amount invested.

Important information

This article is for Professional Clients only and is not for consumer use.

Where individuals or the business have expressed opinions, they are based on current market conditions, they may differ from those of other investment professionals and are subject to change without notice.

Issued by Invesco Asset Management Limited, Perpetual Park, Perpetual Park Drive, Henley-on-Thames, Oxfordshire RG9 1HH, UK. Authorised and regulated by the Financial Conduct Authority.

Advertisement

More on Emerging markets

Thomas Coughlin of Kinesis Money

Fool me twice: The lessons we are yet to learn in the 100 years since Weimar hyperinflation

Need to recognise inherent flaws in current system

Thomas Coughlin
clock 22 October 2021 • 3 min read
The bank has pushed back against claims it may offload its asset management arm

State Street disavows claims of asset management sale - reports

Sparked by Invesco rumours

James Baxter-Derrington
clock 22 October 2021 • 1 min read
St James's Place CEO Andrew Croft

St James's Place AUM up 25% year-on-year

Improving consumer confidence fuelled net inflows

Jenny Turton
clock 21 October 2021 • 1 min read